Stockreport

Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150 [Yahoo! Finance]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF cancer indications, combined with KEYTRUDA's continued growth and a deepening pipeline of 80 Phase 3 studies, will drive a pipeline-driven rerating through 2026. The a [Read more]